Katherine K. Matthay

Also affiliated with University of California San Diego, UCSF Benioff Children's Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.”.

Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10526

N/A

0DataRank · unranked

9 citations

Jennifer Michlitsch, Avanthi Tayi Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham +7 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10523

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Wendy B. London, Sheena C. Tenney +11 more

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3909

N/A

0DataRank · unranked

216 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures

Radiation Research(2021)10.1667/rade-20-00173.1

N/A

0DataRank · unranked

6 citations

Tim Setzkorn, David A. Edmondson, Haley Segelke, Paul F. Wilson, Katherine K. Matthay +6 more

Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Pediatric Blood & Cancer(2022)10.1002/pbc.29616

N/A

0DataRank · unranked

14 citations

Steven G. DuBois, John Neuhaus, Steve Braunstein, Brent R. Weil, Arlene Naranjo +4 more

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Cancer(2022)10.1002/cncr.34445

N/A

0DataRank · unranked

14 citations

Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus Beiske +9 more

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10041

N/A

0DataRank · unranked

0 citations

Yaël P. Mossé, Kimberly Kayser, Yueh‐Yun Chi, Marc Chioda, Holger Thurm +14 more

Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10027

N/A

0DataRank · unranked

0 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e22003

N/A

0DataRank · unranked

0 citations

Katherine K. Matthay, Susan Groshen, Yueh‐Yun Chi, Meaghan Granger, Julie R. Park +3 more

Impact of diagnostic and end‐of‐induction Curie scores with tandem high‐dose chemotherapy and autologous transplants for metastatic high‐risk neuroblastoma: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30418

N/A

0DataRank · unranked

10 citations

Marguerite T. Parisi, Barry L. Shulkin, Brian LaBarre, Rochelle Bagatell, Lisa Diller +9 more

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma

Cell Reports(2023)10.1016/j.celrep.2023.112879

N/A

0DataRank · unranked

9 citations

Erez Greenstein, Martin L. Buchkovich, Ayelet Peres, Eric Santoni‐Rugiu, Lei Yang +16 more

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory neuroblastoma

Pediatric Blood & Cancer(2023)10.1002/pbc.30743

N/A

0DataRank · unranked

5 citations

Ajami Gikandi, Bruce Pawel, Daniel Martínez, Meaghan Granger, Araz Marachelian +6 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294.v1

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

ALK upregulates POSTN and WNT signaling to drive neuroblastoma

Cell Reports(2024)10.1016/j.celrep.2024.113927

N/A

0DataRank · unranked

16 citations

Wanqi Fang, Alvin Farrel, Linwei Li, Antonios Chronopoulos, Nicole Nasholm +17 more

Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2024)10.1002/pbc.31039

N/A

0DataRank · unranked

2 citations

Victoria W. Willard, Leanne Embry, Arlene Naranjo, Brian LaBarre, Katherine K. Matthay +2 more